MDM2-mediated Degradation of P14ARF: a Novel Mechanism to Control ARF Levels in Cancer Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Feb 28

PMID 25723571

Citations 15

Authors

Maria Vivo

Maria Matarese

Maria Sepe

Rosaria Di Martino

Luisa Festa

Viola Calabro

Girolama La Mantia

Alessandra Pollice

Affiliations

Soon will be listed here.

Abstract

We here show a new relationship between the human p14ARF oncosuppressor and the MDM2 oncoprotein. MDM2 overexpression in various cancer cell lines causes p14ARF reduction inducing its degradation through the proteasome. The effect does not require the ubiquitin ligase activity of MDM2 and preferentially occurs in the cytoplasm. Interestingly, treatment with inhibitors of the PKC (Protein Kinase C) pathway and use of p14ARF phosphorylation mutants indicate that ARF phosphorylation could play a role in MDM2 mediated ARF degradation reinforcing our previous observations that ARF phosphorylation influences its stability and biological activity. Our study uncovers a new potentially important mechanism through which ARF and MDM2 can counterbalance each other during the tumorigenic process.

Citing Articles

High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.

Dong Y, Zheng M, Wang X, Yu C, Qin T, Shen X BMC Cancer. 2023; 23(1):1097.

PMID: 37950153 PMC: 10638725. DOI: 10.1186/s12885-023-11603-w.

Light Quality Potentiates the Antioxidant Properties of Microgreen Extracts against Oxidative Stress and DNA Damage in Human Cells.

Paolillo I, Costanzo G, Delicato A, Villano F, Arena C, Calabro V Antioxidants (Basel). 2023; 12(10).

PMID: 37891974 PMC: 10604222. DOI: 10.3390/antiox12101895.

Modulation of intestinal epithelial cell proliferation and apoptosis by Lactobacillus gasseri SF1183.

Luccia B, Acampora V, Saggese A, Calabro V, Vivo M, Angrisano T Sci Rep. 2022; 12(1):20248.

PMID: 36424419 PMC: 9691729. DOI: 10.1038/s41598-022-24483-0.

Mutation of the Conserved Threonine 8 within the Human ARF Tumour Suppressor Protein Regulates Autophagy.

Fontana R, Guidone D, Angrisano T, Calabro V, Pollice A, La Mantia G Biomolecules. 2022; 12(1).

PMID: 35053274 PMC: 8773949. DOI: 10.3390/biom12010126.

In Vitro and In Vivo Toxicity Evaluation of Natural Products with Potential Applications as Biopesticides.

Sangermano F, Masi M, Kumar A, Peravali R, Tuzi A, Cimmino A Toxins (Basel). 2021; 13(11).

PMID: 34822589 PMC: 8617648. DOI: 10.3390/toxins13110805.

References

Korgaonkar C, Zhao L, Modestou M, Quelle D . ARF function does not require p53 stabilization or Mdm2 relocalization. Mol Cell Biol. 2001; 22(1):196-206. PMC: 134207. DOI: 10.1128/MCB.22.1.196-206.2002. View

Chen D, Shan J, Zhu W, Qin J, Gu W . Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses. Nature. 2010; 464(7288):624-7. PMC: 3737736. DOI: 10.1038/nature08820. View

Montes de Oca Luna R, Wagner D, Lozano G . Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature. 1995; 378(6553):203-6. DOI: 10.1038/378203a0. View

Llanos S, Clark P, Rowe J, Peters G . Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat Cell Biol. 2001; 3(5):445-52. DOI: 10.1038/35074506. View

Vivo M, Di Costanzo A, Fortugno P, Pollice A, Calabro V, La Mantia G . Downregulation of DeltaNp63alpha in keratinocytes by p14ARF-mediated SUMO-conjugation and degradation. Cell Cycle. 2009; 8(21):3545-51. DOI: 10.4161/cc.8.21.9954. View

Rizos H, Darmanian A, Mann G, Kefford R . Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization. Oncogene. 2000; 19(26):2978-85. DOI: 10.1038/sj.onc.1203629. View

Kulikov R, Letienne J, Kaur M, Grossman S, Arts J, Blattner C . Mdm2 facilitates the association of p53 with the proteasome. Proc Natl Acad Sci U S A. 2010; 107(22):10038-43. PMC: 2890462. DOI: 10.1073/pnas.0911716107. View

Colombo E, Martinelli P, Zamponi R, Shing D, Bonetti P, Luzi L . Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Cancer Res. 2006; 66(6):3044-50. DOI: 10.1158/0008-5472.CAN-05-2378. View

Sepe M, Festa L, Tolino F, Bellucci L, Sisto L, Alfano D . A regulatory mechanism involving TBP-1/Tat-Binding Protein 1 and Akt/PKB in the control of cell proliferation. PLoS One. 2011; 6(10):e22800. PMC: 3186787. DOI: 10.1371/journal.pone.0022800. View

10.

Sdek P, Ying H, Chang D, Qiu W, Zheng H, Touitou R . MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell. 2005; 20(5):699-708. DOI: 10.1016/j.molcel.2005.10.017. View

11.

Zhang Y, Xiong Y . Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ. 2001; 12(4):175-86. View

12.

Shimizu T, Ishikawa T, Sugihara E, Kuninaka S, Miyamoto T, Mabuchi Y . c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis. Oncogene. 2010; 29(42):5687-99. DOI: 10.1038/onc.2010.312. View

13.

Yu Z, Geyer R, Maki C . MDM2-dependent ubiquitination of nuclear and cytoplasmic P53. Oncogene. 2000; 19(51):5892-7. DOI: 10.1038/sj.onc.1203980. View

14.

Galli F, Rossi M, DAlessandra Y, De Simone M, Lopardo T, Haupt Y . MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J Cell Sci. 2010; 123(Pt 14):2423-33. DOI: 10.1242/jcs.061010. View

15.

Lohrum M, Ashcroft M, Kubbutat M, Vousden K . Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization. Curr Biol. 2000; 10(9):539-42. DOI: 10.1016/s0960-9822(00)00472-3. View

16.

Pollice A, Sepe M, Villella V, Tolino F, Vivo M, Calabro V . TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation. Oncogene. 2007; 26(35):5154-62. DOI: 10.1038/sj.onc.1210313. View

17.

Brady C, Attardi L . p53 at a glance. J Cell Sci. 2010; 123(Pt 15):2527-32. PMC: 2912460. DOI: 10.1242/jcs.064501. View

18.

Weber J, Kuo M, Bothner B, DiGiammarino E, Kriwacki R, Roussel M . Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol Cell Biol. 2000; 20(7):2517-28. PMC: 85460. DOI: 10.1128/MCB.20.7.2517-2528.2000. View

19.

Eymin B, Gazzeri S, Brambilla C, Brambilla E . Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors. Oncogene. 2002; 21(17):2750-61. DOI: 10.1038/sj.onc.1205359. View

20.

Pollice A, Vivo M, La Mantia G . The promiscuity of ARF interactions with the proteasome. FEBS Lett. 2008; 582(23-24):3257-62. DOI: 10.1016/j.febslet.2008.09.026. View